Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis.

MLA

Cheng, Joyce M., et al. “Exceptional Responses to PARP Inhibitors in Patients with Metastatic Breast Cancer in Oncologic Crisis.” Breast Cancer Research & Treatment, vol. 199, no. 2, June 2023, pp. 389–97. EBSCOhost, https://doi.org/10.1007/s10549-023-06910-6.

APA

Cheng, J. M., Canzoniero, J., Lee, S., Soni, S., Mangini, N., & Santa-Maria, C. A. (2023). Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. Breast Cancer Research & Treatment, 199(2), 389–397. https://doi.org/10.1007/s10549-023-06910-6

Chicago

Cheng, Joyce M., Jenna Canzoniero, Seoho Lee, Sudeep Soni, Neha Mangini, and Cesar A. Santa-Maria. 2023. “Exceptional Responses to PARP Inhibitors in Patients with Metastatic Breast Cancer in Oncologic Crisis.” Breast Cancer Research & Treatment 199 (2): 389–97. doi:10.1007/s10549-023-06910-6.